Sorrento Therapeutics Logo Image

Sorrento Therapeutics

Most Recent Annual Report

2019 Annual Report and Form 10K

Sorrento Therapeutics

Sorrento Therapeutics has reached its limit for free report views.

Sorrento Therapeutics does not currently have any hardcopy reports on Click the button below to request a report when hardcopies become available.

Archived Annual Reports

About Sorrento Therapeutics

51-200 Employees
Based in San Diego, California

Sorrento Therapeutics is an antibody-centric, clinical stage biopharmaceutical company developing new treatments for cancer, inflammation and autoimmune diseases. Sorrento's lead products are multiple late-stage biosimilar and biobetter antibodies, as well as clinical CAR-T therapies targeting solid tumors.

NASDAQ (See More NASDAQ Companies)
Biotechnology (See More Biotechnology Companies)
Healthcare (See More Healthcare Companies)

Looking for Other Annual Reports?

Search by company name or ticker symbol